MOLECULAR MEDICINE OFFERS PROMISE FOR THE prevention of vision loss caused by
ocular neo-vascularization in diabetic retinopathy and exudative age-related macular
degeneration (ARMD). During the past decade, significant advances have been made in
angiogenesis research, such that the understanding about new vessel formation in disease
has increased considerably. This knowledge has led to the development of numerous
inhibitors of angiogenesis. Among a host of novel therapeutics for ocular neovascularization …